Narrow-leaved Cleome

Cleome angustifolia contains flavonoids (notably rutin and naringenin), phenolic acids (including syringic acid, gallic acid, and ellagic acid), sterols (β-sitosterol), and alkaloids that collectively exert antioxidant, anti-inflammatory, and putative antiviral effects by scavenging reactive oxygen species and inhibiting cyclooxygenase enzymes. San traditional healers have long applied preparations of this plant to treat influenza-like illness, a use that aligns with the documented immunomodulatory and anti-inflammatory bioactivity observed in closely related Cleome species in preclinical models, though no controlled clinical trials have yet validated efficacy specifically for C. angustifolia.

Origin & History

Cleome angustifolia is native to arid and semi-arid regions of sub-Saharan Africa and the Arabian Peninsula, thriving in sandy soils, rocky outcrops, and disturbed habitats at low to mid elevations. It is a member of the family Cleomaceae (formerly placed within Capparaceae), adapted to hot, dry climates with sparse rainfall, and is found across the Sahel, East Africa, and southern African regions including areas inhabited by San (Bushmen) communities. The plant grows as an annual or short-lived perennial herb, typically reaching 20–60 cm in height, and is not widely cultivated commercially, being harvested from wild populations for traditional medicinal use.

Historical & Cultural Context

Cleome angustifolia holds documented significance in the ethnobotanical repertoire of the San peoples of southern Africa, one of the world's oldest continuous cultures, who have employed the plant in the management of influenza-like illness, underscoring a deep observational tradition linking the herb's anti-inflammatory and febrifuge properties to respiratory infection. Across the broader Cleome genus, African and Middle Eastern traditional medicine systems have prescribed preparations for a wide spectrum of conditions including stomachache, skin inflammation, wounds, and metabolic disorders, reflecting the genus's chemical richness in bioactive polyphenols and alkaloids. Preparation in these traditions typically involved decoctions or poultices of fresh or dried aerial parts, with knowledge transmitted orally within communities and rarely formalized in written pharmacopoeias. The Cleomaceae family's traditional application in hepatoprotection and antidiabetic management across North Africa and the Sahel further contextualizes C. angustifolia within a continent-wide pattern of medicinal spider-flower use that predates formal pharmacology by millennia.

Health Benefits

- **Antioxidant Protection**: Flavonoids such as rutin and phenolic acids including ellagic acid and gallic acid scavenge DPPH and ABTS free radicals; closely related Cleome droserifolia ethanolic extracts achieved an IC₅₀ of 8.95 ± 1.023 µg/mL, suggesting potent radical-quenching capacity attributable to the shared polyphenol profile.
- **Anti-inflammatory Action**: Genus-shared bioactives inhibit cyclooxygenase enzymes COX-1 and COX-2, with C. droserifolia extracts yielding IC₅₀ values of 12.91 ± 0.5 µg/mL and 21.63 ± 0.8 µg/mL respectively; this mechanism underpins the traditional use of Cleome preparations for fever and respiratory inflammation associated with influenza.
- **Immunomodulatory Support**: In vivo studies with C. droserifolia methanolic extract demonstrated reduced plasma IL-1β concentrations, improved redox status, and elevated lysozyme activity in blood plasma, indicating modulation of innate immune defenses relevant to infectious respiratory illness.
- **Antidiabetic Potential**: Flavonols extracted from Cleome aqueous preparations exhibited approximately 63.3% inhibition of glucose-metabolizing enzymes in vitro compared with metformin, with amylase inhibition documented at IC₅₀ 14.93 ± 1.87 µg/mL in C. droserifolia, suggesting blood-glucose-lowering utility shared across the genus.
- **Antimicrobial Activity**: Cleome genus phenolics and alkaloids have demonstrated broad-spectrum antibacterial activity against enteric pathogens; in vivo supplementation with C. droserifolia extract suppressed Salmonella and coliform bacterial counts while promoting beneficial Lactobacillus and yeast populations in the gut microbiota.
- **Hepatoprotective Effects**: β-sitosterol and polyphenolic constituents common to Cleome species are associated with hepatoprotective activity documented across the genus, likely through attenuation of oxidative stress and inflammatory signaling in hepatocytes, consistent with the traditional pan-African use of Cleome preparations for liver complaints.
- **Analgesic Properties**: Alkaloids and flavonoids within the Cleome genus are linked to central and peripheral analgesic mechanisms, supporting ethnobotanical reports of pain relief from plant preparations, which would complement symptom management in influenza-related myalgia and headache.

How It Works

The principal antioxidant mechanism involves hydrogen-atom and single-electron transfer by polyphenols — particularly rutin (quantified at up to 15,900 µg/g in related species) and ellagic acid — to neutralize superoxide, hydroxyl, and peroxyl radicals, thereby reducing oxidative tissue damage during viral infection. Anti-inflammatory activity is mediated primarily through competitive inhibition of arachidonic acid binding at the active sites of COX-1 and COX-2, limiting prostaglandin E₂ and thromboxane synthesis and attenuating the febrile and pro-inflammatory cascade; naringenin and chlorogenic acid are particularly implicated in COX modulation across the Cleomaceae family. The compound 3-ethylsulfonyl-2,3-dimethoxypropyl, isolated from the closely related Cleome africana, demonstrates in silico binding to α-glucosidase active sites via molecular docking, representing a structurally unique sulfonyl-propyl scaffold with enzyme-inhibitory potential. Immunomodulation appears to proceed through downregulation of IL-1β cytokine expression and upregulation of lysozyme, a bacteriolytic enzyme of innate immunity, as observed in animal models supplemented with Cleome methanolic extracts, suggesting pleiotropic modulation of both adaptive and innate immune arms relevant to influenza management.

Scientific Research

The evidence base for Cleome angustifolia specifically is essentially absent in the peer-reviewed literature, with no published pharmacological studies identified that examine this precise species; all quantitative data are extrapolated from closely related congeners, principally Cleome droserifolia and Cleome africana, and should be interpreted with caution regarding applicability to C. angustifolia. Available preclinical data consist of in vitro assays (DPPH/ABTS scavenging, COX inhibition, enzyme inhibition) and a small, unspecified-sample-size in vivo rabbit feeding study, placing the overall genus evidence squarely in the preliminary tier. No randomized controlled trials, observational cohort studies, or human pharmacokinetic studies have been conducted on any Cleome species for influenza treatment or any other indication, and the antidiabetic in vitro comparison with metformin (63.3% activity) lacks rigorous experimental controls adequate for clinical extrapolation. Systematic reviews of the Cleomaceae family call explicitly for toxicological profiling, bioavailability studies, and controlled in vivo experiments before therapeutic claims can be substantiated.

Clinical Summary

No clinical trials have been conducted on Cleome angustifolia, and no human interventional studies exist for any species in the Cleome genus regarding influenza treatment or immunomodulation. The sole in vivo controlled experiment identified involved rabbits administered C. droserifolia methanolic extract, which produced measurable reductions in plasma IL-1β and improvements in oxidative status and lysozyme activity relative to untreated controls, though sample size and dosing details were not reported in accessible literature. In vitro data demonstrate meaningful antioxidant potency (IC₅₀ ~8.95 µg/mL) and COX inhibition (IC₅₀ 12.91–21.63 µg/mL) for genus extracts, but these outcomes do not translate directly to clinical efficacy without pharmacokinetic and human exposure data. Confidence in therapeutic outcomes for C. angustifolia specifically remains very low, and its use for influenza is currently supported only by San ethnobotanical tradition and mechanistic plausibility from congener research.

Nutritional Profile

Cleome angustifolia has not been subjected to formal proximate nutritional analysis; available phytochemical data are derived from related species and indicate that the aerial parts are rich in polyphenolic secondary metabolites rather than macro- or micronutrients in pharmacologically meaningful quantities. Flavonoids — particularly rutin (up to ~15,900 µg/g in ethanolic extracts of C. droserifolia shoots) and naringenin — dominate the bioactive fraction, alongside phenolic acids including syringic acid (~5,320 µg/g), ellagic acid (~2,830 µg/g), vanillin (~1,425 µg/g), gallic acid (~1,150 µg/g), and chlorogenic acid (~987 µg/g) as quantified by HPLC in congener studies. Sterols, notably β-sitosterol, are present and contribute to anti-inflammatory and potentially cholesterol-modulating effects, though concentrations in C. angustifolia are unreported. Bioavailability of polyphenols such as rutin is generally moderate (oral bioavailability ~20–40% for rutin as a glycoside, improved by gut microbiota hydrolysis to quercetin aglycone), and fat-soluble phytosterols require dietary lipid co-ingestion for optimal absorption.

Preparation & Dosage

- **Traditional Decoction (Whole Herb)**: Aerial parts (leaves, stems, and flowers) are boiled in water for 15–30 minutes and consumed as a warm tea; specific volumes are undocumented for C. angustifolia but analogous San preparations typically involve 1–2 cups daily during acute illness.
- **Ethanolic Extract (Research Form)**: Laboratory studies of related species use ethanolic extracts standardized to total phenolic content, tested at concentrations of 1 mg/mL maximum in antioxidant assays; no commercial supplement dose has been established.
- **Methanolic Extract (Research Form)**: Methanolic extracts of Cleome shoots/leaves are prepared via cold maceration or Soxhlet extraction for phytochemical analysis; in vivo animal studies administered extracts orally at unspecified milligram-per-kilogram doses.
- **Aqueous Infusion (Traditional)**: Cold or hot water infusions of dried leaves represent the most accessible traditional preparation method across African communities; standardization is absent and active compound yield is expected to be lower than alcoholic extracts.
- **No Established Therapeutic Dose**: No safe or effective supplemental dose has been determined for humans; extrapolation from in vitro µg/mL concentrations to oral human dosing is not scientifically validated at this stage of research.

Synergy & Pairings

Cleome angustifolia preparations may exhibit additive or synergistic antioxidant activity when combined with vitamin C (ascorbic acid), as ascorbate regenerates oxidized flavonoid radicals back to their active reduced form, thereby extending the radical-scavenging cycle of rutin and ellagic acid. The COX-inhibitory phenolics in Cleome may complement the anti-inflammatory activity of boswellic acids (from Boswellia serrata), which target 5-lipoxygenase rather than cyclooxygenase, providing dual-pathway suppression of the eicosanoid inflammatory cascade relevant to respiratory infection management. Co-administration with probiotic Lactobacillus strains is theoretically supported by the genus's documented gut microbiota-modulating effects — specifically the suppression of pathogenic coliforms and Salmonella alongside promotion of Lactobacillus — suggesting a prebiotic-probiotic combinatorial benefit in infectious gastrointestinal and systemic inflammatory contexts.

Safety & Interactions

Formal toxicological studies for Cleome angustifolia do not exist in the peer-reviewed literature, and no LD₅₀, NOAEL, or maximum tolerated dose has been established for any preparation of this species in any model organism. In vivo rabbit studies with related species reported no overt toxicity at tested doses and showed beneficial immunological changes, suggesting reasonable short-term tolerability, but chronic safety, mutagenicity, teratogenicity, and organ-specific toxicity remain entirely uncharacterized. Given the presence of alkaloids in the genus, potential interactions with cytochrome P450 enzymes (particularly CYP3A4 and CYP2D6) cannot be excluded, raising theoretical concern for interactions with anticoagulants, immunosuppressants, antidiabetic medications, and anti-inflammatory drugs; concurrent use with NSAIDs warrants particular caution given shared COX-inhibitory pathways. Use in pregnancy and lactation is not recommended due to complete absence of safety data, and individuals with known allergies to Cleomaceae or Capparaceae family plants should avoid exposure.